Hospital News and Research

RSS

Fidaxomicin, CDA1/CDB1 effective for treating CDI : Report

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in first- and second-line treatment of Clostridium difficile infection, nearly 70 percent of surveyed infectious disease specialists and internists will use Optimer's fidaxomicin and nearly half will use Medarex/Merck's CDA1 and CDB1, one year after the launch of these agents. The lower recurrent/relapse rate associated with fidaxomicin and CDA1/CDB1 is the most influential attribute surveyed clinicians cite in their decisions to prescribe these emerging agents for CDI.

6 Aug 2010

Researchers recommends robotic prostatectomy over traditional open surgery method

While sharp debate continues among medical professionals as to whether a radical prostatectomy performed with the assistance of a robotic device is more beneficial than the traditional open surgery method, research just published by investigators at The Cancer Institute of New Jersey (CINJ) shows new evidence supporting the safety of the robotic procedure - including what is believed to be one of the lowest complication rates to date. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

6 Aug 2010

Alnylam publishes research findings of Sort1 gene role in cardiovascular disease development

Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, announced today the publication of new research findings in the journal Nature describing the discovery and validation of the role of the gene Sort1 in the development of cardiovascular disease, including myocardial infarction (MI). This work was done with collaborators at University of Pennsylvania (UPenn) School of Medicine, Massachusetts General Hospital (MGH), and the Broad Institute. The collaborative effort combined genome-wide association studies (GWAS) and RNAi technology to identify and validate novel genes as targets for new therapies for heart disease.

6 Aug 2010

Study identifies options for restoring knee cartilage lubrication to prevent OA

An injury to the anterior cruciate ligament is fairly common, especially among young athletes. While it can often be corrected through surgery, the injury can lead to increased risk of developing degenerative joint diseases, including osteoarthritis. The problem is that fluid in the knee joint, which lubricates the cartilage, is impacted by the trauma of the injury and begins to deteriorate.

6 Aug 2010

VWR International signs agreement to acquire scientific distribution businesses of EBOS Group

VWR International, LLC, a leading global laboratory supply and distribution company, announced today that it has signed an agreement to acquire the scientific distribution businesses of EBOS Group Limited, subject to customary closing conditions. The parties anticipate completion of the transaction on or about September 1, 2010.

6 Aug 2010

Akonni Biosystems receives patent for TruTip Extraction Kits

Akonni Biosystems, a developer of low-cost, multiplex molecular diagnostic testing systems, today announced that the United States Patent and Trademark Office issued a patent on July 20, 2010 for its method for rapidly purifying nucleic acids. U.S. Patent No. 7,759,112 entitled, "Apparatus, system, and method for purifying nucleic acids" protects the Company's use of its pioneering nucleic acid binding matrix when inserted into a pipette tip, tubing or cartridge for nucleic acid purification. The patent is owned by Akonni Biosystems.

6 Aug 2010

Split-dosage method effective for bowel cleansing before colonoscopy: Study

A new study from researchers in Italy has found that a split-dosage schedule of bowel (colon) preparation is the most effective method for bowel cleansing before colonoscopy. Colonoscopies performed within six to eight hours of the end of preparation were associated with significantly better cleansing than those performed more than eight hours after the end of preparation. Two different types of bowel cleansing products were also assessed and researchers found that low-volume polyethylene glycol (PEG) plus ascorbic acid was as effective as high-volume PEG-electrolyte solution, but has superior palatability (or taste). This is the first study to demonstrate that the advantage of split-dosage intake is also true for low-volume bowel cleansing solutions.

6 Aug 2010

EMRs bring new risks as national push ramps up

Two electronic medical record snafus in two weeks at a Midwestern hospital chain are raising questions about the safety of such health IT systems, The Huffington Post Investigative Fund reports.

6 Aug 2010

NAEDI aims to correct survival gap in cancer diagnosis

Cancer Research UK today reveals that as many as 11,000 deaths from cancer could be prevented annually if Great Britain raised its survival figures to match those of the best performing countries in Europe.Cancer Research UK and national cancer director, Professor Mike Richards, believe that the most important reasons for the survival gap include poor awareness of the symptoms of cancer, late presentation to a GP and, late onward referral to hospital.

6 Aug 2010

New laboratory to speed up research for melanoma treatment set up at University of Bristol

A new Skin Cancer Research Fund Laboratory has been set up in Bristol to study cancer cells collected from skin cancer patients attending Frenchay Hospital. It is hoped the new facility will speed up research into treatments for malignant melanoma - the most deadly form of skin cancer. The new laboratory at the Microvascular Research Laboratories at the University of Bristol will be officially opened today (Tuesday August 22nd) by the director of the Skin Cancer Research Fund, Mr Paul Townsend.

6 Aug 2010

Repligen total revenue for first-quarter fiscal 2011 increases 39% to $7.01 million

Repligen Corporation today reported results for the first quarter of fiscal year 2011, ended June 30, 2010. Total revenue for the first quarter was $7,010,000 compared to total revenue of $5,061,000 for the first quarter of fiscal year 2010, an increase of $1,949,000 or 39%. Bioprocessing product revenue for the first quarter was $4,269,000 compared to $2,473,000 for the first quarter of fiscal 2010, an increase of $1,796,000 or 73%.

5 Aug 2010

Cornerstone Therapeutics second-quarter total net revenues increase 14% to $28.5 million

Cornerstone Therapeutics Inc. today reported financial results for the second quarter and six months ended June 30, 2010.

5 Aug 2010

New article highlights importance of patient safety features in design of IV needleless connectors

A new article by infection control expert William Jarvis, M.D., President, Jason and Jarvis Associates, LLC, highlights the importance of patient safety features in the design of IV needleless connectors.

5 Aug 2010

New study on decision making for infants with complex life threatening illnesses

Sharron Docherty understands that medical care for a critically ill infant involves much more than treatments designed to bring about a cure.

5 Aug 2010

New studies question wide-spread hypothesis that CCSVI contribute to development of MS

Researchers at Umeå University in Sweden have performed a study that indicates that neither blood flow nor the flow of spinal fluid in the brain contribute to the development of multiple sclerosis, MS. The findings run directly counter to a much-discussed and widely spread Italian theory.

5 Aug 2010

Censis launches ScopeTrac endoscope tracking and reprocessing data management solution

Censis® Technologies, Inc., developer of Censitrac™ surgical instrument tracking systems, has introduced ScopeTrac, an endoscope tracking and reprocessing data management solution designed to help prevent inappropriate endoscope reprocessing.

5 Aug 2010

UCI School of Medicine's incoming students to receive iPad tablet computer as part of iMedEd Initiative

Traditionally, first-year medical students are awarded white coats to signify their entry into the medical community. But at an Aug. 6 ceremony, each member of the UC Irvine School of Medicine's incoming class of 2014 will find a surprise tucked into the coat's pocket: an iPad tablet computer pre-loaded with everything necessary for the first year of course work.

5 Aug 2010

Diabetes Self-Management Training helps to prevent complications in pre diabetes patients

Citing research that demonstrates the cost savings and health benefits of providing Diabetes Self-Management Training (DSMT) to patients with pre-diabetes, the American Association of Diabetes Educators today called on private insurers and Medicare to include education as a covered benefit for this population.

5 Aug 2010

Scientists to develop new antibiotics to tackle infection-causing bacteria

Detailed pictures published today reveal how a new type of experimental antibiotic can kill bacteria that are already resistant to existing treatments. The findings could ultimately help scientists to develop new antibiotics to tackle the bacteria responsible for many hospital and community-acquired infections.

5 Aug 2010

Cross Country Healthcare reports $117.8M revenue, $1.2M net income for second-quarter 2010

Cross Country Healthcare, Inc. today reported revenue of $117.8 million in the second quarter ended June 30, 2010, and net income of $1.2 million, or $0.04 per diluted share. This compares to revenue of $149.0 million in the prior year quarter and net income of $2.3 million, or $0.07 per diluted share. Cash flow from operations for the second quarter of 2010 was $13.4 million.

5 Aug 2010

Hospital News and Research

Fidaxomicin, CDA1/CDB1 effective for treating CDI : Report

Researchers recommends robotic prostatectomy over traditional open surgery method

Alnylam publishes research findings of Sort1 gene role in cardiovascular disease development

Study identifies options for restoring knee cartilage lubrication to prevent OA

VWR International signs agreement to acquire scientific distribution businesses of EBOS Group

Akonni Biosystems receives patent for TruTip Extraction Kits

Split-dosage method effective for bowel cleansing before colonoscopy: Study

EMRs bring new risks as national push ramps up

NAEDI aims to correct survival gap in cancer diagnosis

New laboratory to speed up research for melanoma treatment set up at University of Bristol

Repligen total revenue for first-quarter fiscal 2011 increases 39% to $7.01 million

Cornerstone Therapeutics second-quarter total net revenues increase 14% to $28.5 million

New article highlights importance of patient safety features in design of IV needleless connectors

New study on decision making for infants with complex life threatening illnesses

New studies question wide-spread hypothesis that CCSVI contribute to development of MS

Censis launches ScopeTrac endoscope tracking and reprocessing data management solution

UCI School of Medicine's incoming students to receive iPad tablet computer as part of iMedEd Initiative

Diabetes Self-Management Training helps to prevent complications in pre diabetes patients

Scientists to develop new antibiotics to tackle infection-causing bacteria

Cross Country Healthcare reports $117.8M revenue, $1.2M net income for second-quarter 2010

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News